Cell line · CVCL_0559
TF-1
Cancer cell line, Homo sapiens. Erythroleukemia. 37 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. TF-1. Cell lines, record CVCL_0559. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0559
On this page
Cell line
As Cellosaurus gives it.
- Name
- TF-1
- Accession
- CVCL_0559
- RRID
- RRID:CVCL_0559
- Synonyms
- TF1, MFD-1
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 35Y
- Category
- Cancer cell line
- Diseases
- Erythroleukemia (NCIt C7152); Acute erythroid leukemia (ORDO Orphanet_318)
- Derived from
- Bone marrow (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers37
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| DNA Methylation Stochasticity Is Linked to Transcriptional Variability and Convergent Epigenetic Disruption across Genetic Subtypes of Acute Myeloid Leukemia. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MiR-513a promotes human erythroid differentiation by modulating c-Jun. | FEBS Open Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL Leukemia. | Cancer Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis. | Cancer Discov | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15. | iScience | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths. | Cell Stem Cell | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML. | Clin Cancer Res | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research. | Int J Mol Sci | 2023 | Cellosaurus cites it | PubMed |
1 to 10 of 37
See all 37 papersRelatives10
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | CellSensor irf1-bla TF1 | CVCL_KS74 | Cell lines | |
| Derived from it | LanthaScreen STAT5 TF-1 | CVCL_ZJ11 | Cell lines | |
| Derived from it | TF-1 BCR/ABL | CVCL_J294 | Cell lines | |
| Derived from it | TF-1 D2 | CVCL_8059 | Cell lines | |
| Derived from it | TF-1 D8 | CVCL_8060 | Cell lines | |
| Derived from it | TF-1 IDH2 p.R140Q | CVCL_UE10 | Cell lines | |
| Derived from it | TF-1-Luc2 | CVCL_A4BP | Cell lines | |
| Derived from it | TF-1.CN5a.1 | CVCL_3607 | Cell lines | |
| Derived from it | TF-1/TPO | CVCL_RM06 | Cell lines | |
| Derived from it | TF-1a | CVCL_3608 | Cell lines |
Cell banks10
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-2003 | ATCC | |
| BCRC | 60323 | BCRC | |
| BCRJ | 0233 | Discontinued | Cellosaurus |
| CCTCC | GDC0196 | Cellosaurus | |
| CLS | 300434 | CLS | |
| DSMZ | ACC-334 | DSMZ | |
| ECACC | 93022307 | ECACC | |
| EDITGENE | EDC00351 | EDITGENE | |
| ICLC | HTL05001 | ICLC | |
| NCBI_Iran | C602 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0559
GET https://conductscience.org/api/cell-lines/v1/CVCL_0559/papers?page=2